TrialNeuro-oncology2026

ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: A single-arm, phase 1/2 study.

Wei Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.